Diorasis, Northway Biotech team up on glaucoma gene therapy development
Diorasis Therapeutics (DTx’s), a preclinical-stage biotechnology firm specialising in gene therapies for ophthalmic conditions, has joined forces with Northway Biotech (NBT), a contract development and manufacturing organisation (CDMO). This collaboration …